Bridgewater Associates’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,663
Closed -$259K 773
2024
Q4
$259K Buy
+5,663
New +$254K ﹤0.01% 648
2023
Q4
Sell
-75,849
Closed -$3.26M 799
2023
Q3
$3.26M Sell
75,849
-46,544
-38% -$2.17M 0.02% 427
2023
Q2
$5.84M Sell
122,393
-46,861
-28% -$2.26M 0.04% 282
2023
Q1
$8.24M Buy
169,254
+22,338
+15% +$1.14M 0.05% 228
2022
Q4
$7.77M Buy
146,916
+1,599
+1% +$78.8K 0.04% 279
2022
Q3
$6.36M Buy
145,317
+101,896
+235% +$5.03M 0.03% 335
2022
Q2
$2.17M Buy
43,421
+425
+1% +$20.7K 0.01% 668
2022
Q1
$2.23M Buy
42,996
+3,786
+10% +$195K 0.01% 656
2021
Q4
$2.31M Sell
39,210
-51
-0.1% -$2.92K 0.01% 440
2021
Q3
$2.15M Buy
39,261
+9,493
+32% +$529K 0.01% 427
2021
Q2
$1.53M Buy
+29,768
New +$1.54M 0.01% 531

Other funds holding QGEN

Bridgewater Associates's QGEN Position: Q1 2025 in Review

Bridgewater Associates sold out of Qiagen (QGEN) in Q1 2025, closing a stake of 5,663 shares — an estimated $259K sold.

Bridgewater Associates first reported a position in QGEN in Q2 2021 and held it in 11 quarters. The position peaked at $8.24M in Q1 2023. 298 funds tracked by Wall St. Rank hold QGEN as of Q1 2025.

  • Bridgewater Associates reported no remaining Qiagen position as of Q1 2025 after selling out during the quarter.
  • Bridgewater Associates sold 5,663 Qiagen shares in Q1 2025, an estimated $259K.
  • Bridgewater Associates first reported a position in Qiagen in Q2 2021 and held it in 11 quarters.
  • Bridgewater Associates's Qiagen position peaked at $8.24M in Q1 2023.
  • 298 funds tracked by Wall St. Rank held Qiagen as of Q1 2025.

Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.